全球基因編輯市場規模、佔有率和成長分析：按類型和應用分類 - 產業預測（2023-2030）

Global Gene Editing Market Size, Share, Growth Analysis, By Type(CRISPR/Cas9, TALENS), By Application(Diagnostics, Drug discovery and development) - Industry Forecast 2023-2030

出版日期: 2023年10月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2021年全球基因編輯市場規模為38億美元，從2022年的40.6億美元成長到2030年的68.7億美元，年複合成長率年成長率預計為6.8%。

近年來，該市場經歷了顯著的成長和進步，徹底改變了生物技術和基因研究部門。該市場的推動因素包括個人化醫療需求的不斷成長、基因工程的進步以及研發活動投資的增加。基因編輯的治療應用，例如遺傳疾病的治療、癌症免疫治療和感染疾病，正在引起巨大關注並推動市場成長。此外，農業部門正在迅速採用基因編輯作物來開發提高產量、營養價值和抗病蟲害能力的作物。全球市場的特徵是製藥公司、生技公司和研究機構等主要企業之間競爭激烈。這些公司正在積極尋求策略合作夥伴關係、併購和聯盟，以加強其研究能力並擴大產品系列。由於擁有先進的醫療基礎設施、強大的研究基礎以及對基因組研究的大量投資，北美在全球市場佔據主導地位。然而，由於中國、日本和印度等國家對精準醫療的日益關注、醫療保健成本的上升以及積極的政府配合措施，預計亞太地區將顯著成長。政府的支持性配合措施、學術機構和生物技術公司之間的合作以及進入基因編輯領域的新創公司的增加也推動了該市場的發展。

全球基因編輯市場動態

全球基因編輯市場的促進因素

個人化醫療需求不斷成長

市場的主要驅動力之一是對個人化醫療不斷成長的需求。基因編輯技術提供了根據個人基因組成開發客製化治療方法的潛力。這種個體化的醫療方法有望改善治療結果、減少副作用並提高患者的福祉。對個人化醫療的認知不斷提高以及對標靶治療的需求是基因編輯技術採用和進步的主要驅動力。

全球基因編輯市場的抑制因素

與科技相關的道德和法規問題

市場的主要抑制因素之一是與該技術相關的道德和法規挑戰。遺傳物質的操縱引發了複雜的倫理考慮，特別是在種系編輯和遺傳改變方面。關於基因編輯的道德影響和潛在的長期後果一直存在爭議。此外，管理基因編輯實踐的法律規範因司法管轄區而異，並且不斷發展。全面的道德準則和明確的法規途徑的需求是市場成長和廣泛採用的主要抑制因素。

全球基因編輯市場趨勢

主要市場趨勢之一是日益關注治療應用和基因療法開發。基因編輯技術為遺傳性疾病和癌症等疾病的標靶和精準治療開闢了新的可能性。市場正在轉向治療方法研究和臨床應用，越來越多的公司和研究人員探索基因編輯作為未滿足醫療需求的潛在解決方案。這一趨勢反映了基因編輯在醫學領域的變革潛力，以及對可直接解決疾病潛在遺傳原因的創新治療方法的追求。

本報告針對全球基因編輯市場進行研究與分析，提供市場動態與前景、細分分析、公司簡介等。

Allele Biotech (US)
GE Healthcare (US)
Bio-Rad (US)
CRISPR Therapeutics (Switzerland)
Merck KGaA (Germany)
OriGene Technologies (US)
Precision Biosciences (US)
Takara Bio (Japan)
Addgene (US)
Thermo Fisher Scientific Inc. (US)
Editas Medicine (US)
Sangamo Therapeutics (US)
Lonza Group (Switzerland)
Horizon Discovery (UK)
Intellia Therapeutics (US)
Caribou Biosciences (US)
Synthego (US)
GenScript Biotech Corporation (China)
CRISPR/Cas9 Ltd. (UK)
Inscripta (US)

簡介目錄

Product Code: SQMIG35H2103

Global Gene Editing Market size was valued at USD 3.8 billion in 2021 and is poised to grow from USD 4.06 billion in 022 to USD 6.87 billion by 2030, growing at a CAGR of 6.8% during the forecast period (2023-2030).

The Global Gene Editing Market has experienced significant growth and advancement in recent years, revolutionizing the field of biotechnology and genetic research. Gene editing technologies, such as CRISPR-Cas9, TALENs, and zinc finger nucleases, have emerged as powerful tools for precise modification of DNA sequences in various organisms, including humans. The market is driven by the increasing demand for personalized medicine, advancements in genetic engineering, and rising investments in research and development activities. The therapeutic applications of gene editing, including the treatment of genetic disorders, cancer immunotherapy, and infectious diseases, have gained immense attention, propelling the market growth. Additionally, the agriculture sector has witnessed a surge in the adoption of gene editing techniques to develop crops with improved yield, nutritional value, and resistance to pests and diseases. Global market is characterized by intense competition among key players, including pharmaceutical companies, biotechnology firms, and research institutions. These entities are actively engaged in strategic partnerships, mergers and acquisitions, and collaborations to enhance their research capabilities and expand their product portfolios. North America dominated the global market, driven by the presence of advanced healthcare infrastructure, a strong research base, and substantial investments in genomic research. However, Asia-Pacific is expected to witness significant growth, attributed to the increasing focus on precision medicine, rising healthcare expenditure, and supportive government initiatives in countries like China, Japan, and India. The market is also fueled by supportive government initiatives, collaborations between academic institutions and biotechnology companies, and a growing number of startups entering the gene editing space.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Gene Editing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Editing Market Segmental Analysis

The Global Gene Editing Market is segmented by type, application, and region. Based on type, the market can be segmented into CRISPR/Cas9, TALENS, ZFN, restriction enzymes and others. Based on application, the market is segmented into Diagnostics, Drug discovery and development, cell line, animal and plant genetic engineering and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Gene Editing Market Dynamics

Drivers of the Global Gene Editing Market

Increasing demand for personalized medicine

One key driver of the gene editing market is the increasing demand for personalized medicine. Gene editing technologies offer the potential to develop tailored therapies and treatments based on an individual's genetic makeup. This personalized approach to medicine holds the promise of improved treatment outcomes, reduced side effects, and enhanced patient well-being. The growing awareness of personalized medicine and the need for targeted therapies have been significant drivers in the adoption and advancement of gene editing technologies.

Restraints in the Global Gene Editing Market

Ethical and regulatory challenges associated with the technology

One key restraint of the gene editing market is the ethical and regulatory challenges associated with the technology. The manipulation of genetic material raises complex ethical considerations, particularly when it comes to germline editing and inheritable genetic changes. There are ongoing debates and discussions surrounding the moral implications and potential long-term consequences of gene editing. Additionally, regulatory frameworks governing gene editing practices vary across different jurisdictions and are continuously evolving. The need for comprehensive ethical guidelines and clear regulatory pathways poses a significant restraint to the gene editing market's growth and widespread adoption.

Market Trends of the Global Gene Editing market

One key market trend in the gene editing market is the increasing focus on therapeutic applications and the development of gene therapies. Gene editing technologies have opened up new possibilities for targeted and precise treatments of genetic disorders, cancers, and other diseases. The market is witnessing a shift towards therapeutic research and clinical applications, with a growing number of companies and researchers exploring gene editing as a potential solution for unmet medical needs. This trend reflects the transformative potential of gene editing in the field of medicine and the pursuit of innovative therapies that can directly address underlying genetic causes of diseases.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Gene Editing Market by Type
- Market Overview
- CRISPR/Cas9
- TALENS
- ZFN
- restriction enzymes and others
Global Gene Editing Market by Application
- Market Overview
- Diagnostics
- Drug discovery and development
- cell line
- animal and plant genetic engineering and others
Global Gene Editing Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Allele Biotech (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GE Healthcare (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bio-Rad (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CRISPR Therapeutics (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck KGaA (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- OriGene Technologies (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Precision Biosciences (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Takara Bio (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Addgene (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Thermo Fisher Scientific Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Editas Medicine (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sangamo Therapeutics (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Lonza Group (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Horizon Discovery (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Intellia Therapeutics (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Caribou Biosciences (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Synthego (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GenScript Biotech Corporation (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CRISPR/Cas9 Ltd. (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Inscripta (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments